Literature DB >> 12240804

Latent tuberculosis treatment.

Stan Houston, Richard Long, Vernon Hoeppner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12240804      PMCID： PMC121953     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  Latent tuberculosis infection: old problem, new priorities.

Authors:  Kevin Schwartzman
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

2.  Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

Authors:  M P Hawken; H K Meme; L C Elliott; J M Chakaya; J S Morris; W A Githui; E S Juma; J A Odhiambo; L N Thiong'o; J N Kimari; E N Ngugi; J J Bwayo; C F Gilks; F A Plummer; J D Porter; P P Nunn; K P McAdam
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

3.  A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

Authors:  C C Whalen; J L Johnson; A Okwera; D L Hom; R Huebner; P Mugyenyi; R D Mugerwa; J J Ellner
Journal:  N Engl J Med       Date:  1997-09-18       Impact factor: 91.245

4.  A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

Authors:  F M Gordin; J P Matts; C Miller; L S Brown; R Hafner; S L John; M Klein; A Vaughn; C L Besch; G Perez; S Szabo; W El-Sadr
Journal:  N Engl J Med       Date:  1997-07-31       Impact factor: 91.245

5.  Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-08-31       Impact factor: 17.586

6.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

7.  Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.

Authors:  J W Pape; S S Jean; J L Ho; A Hafner; W D Johnson
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

8.  Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-30

9.  Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.

Authors:  A Mwinga; M Hosp; P Godfrey-Faussett; M Quigley; P Mwaba; B N Mugala; O Nyirenda; N Luo; J Pobee; A M Elliott; K P McAdam; J D Porter
Journal:  AIDS       Date:  1998-12-24       Impact factor: 4.177
  9 in total
  1 in total

1.  Latent tuberculosis: revised treatment guidelines.

Authors:  Erica Weir; David N Fisman
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.